Table:
begin	end	state
1	19	cytoplasmic
20	42	transmembrane
43	58	non-cytoplasmic
59	79	transmembrane
80	90	cytoplasmic
91	109	transmembrane
110	114	non-cytoplasmic
115	137	transmembrane
138	154	cytoplasmic
155	175	transmembrane
176	182	non-cytoplasmic
183	202	transmembrane
203	258	cytoplasmic
259	282	transmembrane
283	297	non-cytoplasmic
298	319	transmembrane
320	325	cytoplasmic
326	344	transmembrane
345	355	non-cytoplasmic
356	379	transmembrane
380	395	cytoplasmic
396	435	transmembrane
436	438	non-cytoplasmic
439	458	cytoplasmic

Input:
>Ga0059261_1777
MHSVSASFAGAPDEEARATVAIILSAAGAALGGLLFGFDTAVISGATQALQLQFGLTDAM
LGFTVASALIGTVLGSLIAGAPADRFGRKGVMLTVAIAYVVSSLGTGLAPDLNAFLVFRF
MGGLAIGAASVVTPIYIAEVSPARFRGRLVAMNQLNIVLGILIAFLSNYIIAGLVQYDVA
WRWMFGIVAVPSTIFLLVTLLLPESPRWLAIHGQADRARDVMQRLGFADPRAELARIELA
EAREEAAGKPRLFQRSHFTPVACAIAIAMFNQLSGINALLYYAPRIFELAGAGADSALLQ
SIAVGGTNLVFTVAALFLIDRFGRRPLLFVGSVICAATLLLVGWQLESAKPDGTLILFGL
LGFIAAFAMSQGAVIWVFISEVFPSAVRGKGQALGSTTHWVMAAAITWAFPVFAASVGGW
VFAFFGAMMLLQLLWTWKFMPETNGIALEDMNLGSARA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server